Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,410 | -14,873 | -52,371 | -35,874 | -22,917 |
| Depreciation Amortization | -3,133 | -1,719 | -2,937 | -1,199 | -529 |
| Accounts payable and accrued liabilities | 2,823 | 1,700 | -261 | -278 | 384 |
| Other Working Capital | -302 | -4,067 | 3,866 | -2,188 | -1,310 |
| Other Operating Activity | 1,618 | 1,100 | 8,639 | 4,789 | 2,527 |
| Operating Cash Flow | $-34,404 | $-17,859 | $-43,064 | $-34,750 | $-21,845 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 28,512 | -9,192 | -171,653 | -122,860 | -30,863 |
| PPE Investments | -16 | -11 | -18 | -4 | N/A |
| Investing Cash Flow | $28,496 | $-9,203 | $-171,671 | $-122,864 | $-30,863 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 30,000 | N/A | N/A |
| Debt Repayment | -739 | -739 | N/A | 0 | 0 |
| Common Stock Issued | 7,938 | 7,938 | 122,229 | 122,619 | N/A |
| Common Stock Repurchased | -32 | -32 | N/A | 0 | N/A |
| Other Financing Activity | -188 | -60 | -476 | 0 | -145 |
| Financing Cash Flow | $6,979 | $7,107 | $151,753 | $122,619 | $-145 |
| Beginning Cash Position | 67,119 | 67,119 | 130,101 | 130,101 | 130,101 |
| End Cash Position | 68,190 | 47,164 | 67,119 | 95,106 | 77,248 |
| Net Cash Flow | $1,071 | $-19,955 | $-62,982 | $-34,995 | $-52,853 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,404 | -17,859 | -43,064 | -34,750 | -21,845 |
| Capital Expenditure | -16 | -11 | -21 | -7 | N/A |
| Free Cash Flow | -34,420 | -17,870 | -43,085 | -34,757 | -21,845 |